mme has been researched along with 3,4-methylenedioxyamphetamine in 1 studies
*3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. [MeSH]
*3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. [MeSH]
| Studies (mme) | Trials (mme) | Recent Studies (post-2010) (mme) | Studies (3,4-methylenedioxyamphetamine) | Trials (3,4-methylenedioxyamphetamine) | Recent Studies (post-2010) (3,4-methylenedioxyamphetamine) |
|---|---|---|---|---|---|
| 173 | 11 | 153 | 4,806 | 77 | 1,373 |
| Protein | Taxonomy | mme (IC50) | 3,4-methylenedioxyamphetamine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.2314 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 2.7129 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.996 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 2.6486 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, LH; Kier, LB | 1 |
1 other study(ies) available for mme and 3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Structure-activity studies on hallucinogenic amphetamines using molecular connectivity.
Topics: Amphetamines; Chemical Phenomena; Chemistry, Physical; Hallucinogens; Models, Chemical; Structure-Activity Relationship | 1977 |